Hub Blogs

Hub Blogs contains fresh contributions written by Financial Independence Hub staff or contributors that have not appeared elsewhere first, or have been modified or customized for the Hub by the original blogger. In contrast, Top Blogs shows links to the best external financial blogs around the world.

How maintaining your Car can save you Thousands

Posted By |

The clatter of an engine, the screech of worn brakes, or the ominous glow of a check engine light are often precursors to hefty repair bills that can drain a bank account. Many vehicle owners view car maintenance as an unwelcome expense, yet a proactive approach to servicing your vehicle can be one of the most effective ways to safeguard your finances. By adhering to a regular maintenance schedule, you’re not just ensuring your car runs smoothly and reliably; you’re actively preventing minor issues from escalating into catastrophic failures that can cost thousands of dollars to rectify, ultimately saving you a significant sum in the long run.

Image Adobe Stock, courtesy Logical Position

By Dan Coconate

Special to Financial Independence Hub

Car repairs can suck the cash right out of your wallet if you aren’t careful. But with regular, proactive care, maintaining your car can save you thousands by helping you avoid surprise bills.

This post breaks down how a few simple habits and a bit of attention can help everyday car owners save more over the life of their vehicle.

Why Car Maintenance pays off

Your vehicle is an investment, and treating it appropriately will pay off in the following ways:

  • Prevents expensive breakdowns: Small problems caught early rarely balloon into wallet-busting repairs. You can save money and avoid the headache (and expense) of having to rent a vehicle. Most importantly, you’ll never be the person stranded with smoke pouring from their engine on a busy freeway.
  • Extends car lifespan: Well-maintained vehicles last longer, delaying the need for a new (and costly) purchase. Instead, you can trade in or sell your vehicle on your terms and timeline.
  • Boosts fuel efficiency: Clean filters, fresh oil, and inflated tires mean fewer stops at the pump. Even if you have good fuel efficiency, the less you have to fill up, the more you save.
  • Higher resale value: Service records and a tidy vehicle earn top dollar if you decide to sell. You can put that money toward your next vehicle, which means you’re ahead of the game.

Key Maintenance Tasks that save Money

Not sure where to start when it comes to maintaining your car to save thousands? Try this checklist:

  • Oil changes: Stick to your manufacturer’s recommended oil change schedule. Old oil leads to engine wear and potentially catastrophic (read: very expensive) failure.
  • Brake pads and fluid: Replacing worn pads is much cheaper than replacing your entire brake system.
  • Air and cabin filters: When clogged, filters make your engine work harder, burning more fuel and costing you more at the pump. Continue Reading…

BMO’s Low Volatility ETFs are built differently — Why that’s a Win for your Portfolio

Posted By |
Image courtesy BMO/Getty Images

By Zayla Saunders, BMO ETFs

(Sponsor Blog)

Markets are noisy right now. Between trade talks, shifting rate expectations and recession whispers, there’s no shortage of turbulence. That’s why low-volatility strategies are back in focus: and BMO’s lineup is standing out.

Not all low-vol ETFs are created equal. In fact, BMO’s low-volatility ETFs have been quietly dominating their corner of the market. Here’s what’s working with the approach and the key differentiators of the methodology.

Source: Morningstar as of March 31, 2024 2

Smart, Targeted Methodology

BMO doesn’t just take the market and strip out the riskiest names. Its methodology is precise, practical, and time tested

Step 1: The Starting Point

BMO begins with a broad universe of stocks that are the largest and most liquid from a particular region — say, Canada or the U.S. — and then ranks them based on historical return volatility (also known as beta). Lower is better here.

Step 2: Ranking

Next, the securities are ranked and selected based on their beta, with lowest betas carrying the highest weight in the portfolio. Beta is calculated using 5-year window, with more weight on recent data. Then the team engages in a fundamental review of securities held.

Step 3: Sector Constraints

Unlike some low-vol strategies that end up extremely overweight in defensive sectors (hello, utilities and consumer staples), BMO imposes sector caps. Why? To ensure diversification and avoid concentration risk. That means that while there will be a tilt towards defensive sectors, you’re building a balanced, resilient portfolio.

The Burning Question: Why ‘Beta’?

Beta and Standard deviation are two of the most common ways to measure a fund’s volatility. The key difference is that beta measures a stock’s volatility relative to the market as a whole, while standard deviation measures the risk of individual stocks.

This is where BMO ETFs stands apart in their strategy: The BMO ETF Low Volatility Strategy uses beta as the primary investment selection and weighting criteria. By constructing ETFs with lower beta securities, the BMO ETF Low Volatility Strategy gives investors access to portfolios that are designed to provide growth while reducing exposure to market risk. Over the long term, low beta stocks may benefit from smaller declines during market corrections and still increase during advancing markets. Additionally, they tend to be more mature and provide higher dividend yield than the broad market.

Beta is a risk metric that measures an investment’s sensitivity to fluctuations in the broad market (market sensitivity). The broad market is assigned a beta value of 1.00, an investment with a beta less than 1.00 indicates the investment is less risky relative to the broad market.

So why now?

Low volatility has always had its place: particularly for long-term investors looking to stay invested through all market cycles, or those who tend to be more emotional around volatility in their portfolio. But right now, the case is even stronger: Continue Reading…

Unlock Healthcare Value and Monthly Income | HHL & HHLE

Posted By |
Image courtesy Harvest ETFs

By Ambrose O’Callaghan, Harvest ETFs

(Sponsor Blog)

The U.S. healthcare sector has faced unique challenges in late 2024 and the first half of 2025. Last year, we provided an in-depth look at global healthcare as a long-term opportunity and examined some of the catalysts and innovations that were impacting the sector. Today, the U.S. and global healthcare space continues to evolve while combatting headwinds in some key areas.

The state of U.S.  healthcare equities

Healthcare performed relatively well in the early part of 2025, despite broader trade uncertainty and macroeconomic headwinds. The medical technology and tools sub-sector experienced some short-term volatility that was driven by the uncertainty surrounding tariffs. That comes as little surprise, considering companies in the space reliance on oversees manufacturing and revenue generation.

Domestic names, like those in Managed care and select Biopharmaceuticals, remained relatively insulated during this period. This stemmed from an easing in the tariff narrative, which was triggered by a sharp drop in several macroeconomic indicators that included manufacturing activity and consumer confidence. As we progressed further into 2025, a cloud of uncertainty crept into healthcare. That contributed to some recent volatility across several sub-sectors. In this article, we have provided some recent catalysts to help investors make sense of the current situation in healthcare.

Drug pricing in 2025

On May 12, 2025, President Donald Trump signed an Executive Order (EO) titled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients.” This EO proclaimed that the Trump administration “will take immediate steps to end global freeloading and, should drug manufacturers fail to offer American consumers, the most-favoured-nation lowest price, my Administration will take additional aggressive action.”

Ultimately, the aim is to align U.S. drug prices more closely with lower prices paid internationally. This EO echoes a summer 2020 Trump-era EO that was blocked in court and failed to be implemented. The current version faces similar hurdles. There is no bipartisan backing for the policy, the legality surrounding it is dubious, and there is opposition among both Democrat and Republican lawmakers.

All of these make the implementation of this EO unlikely. However, we could see pilot programs within the Department of Health and Humans Services (HHS), making attempts to fold the current EO’s proclamations into future IRA negotiations, or more comprehensive legislative proposals.

In addition, there are those who have predicted the policy could reduce the research and development (R&D) budgets further. That could potentially impact innovation and companies that have been propelled due to strong R&D spending. However, the risk may truly lie in the negative sentiment that continues to emerge in the news cycle.

Vaccine market uncertainty

The appointment of Robert F. Kennedy Jr. as the United States Secretary of Health has damaged sentiment for healthcare companies that manufacture vaccines. RFK Jr. is a vocal “vaccine sceptic.” Moreover, the Trump administration has pursued leadership changes at the Food and Drug Administration (FDA), which raises questions about stricter vaccine approval processes going forward.

Merck & Co, the U.S.–based pharmaceutical giant, with its vaccine-related businesses, has felt the pressure. In addition to the political uncertainty, a recent CMS technical document has added to the complexity in the vaccine arena. The report suggested that reformulated drugs may no longer be classified as “new” for Medicare negotiations. This development could impact companies with operations in the “combination therapy” space like Johnson & Johnson’s Darzalex Faspro, or Bristol Myers’ subcutaneous version of Opdivo. That could affect future patent projections as well. Continue Reading…

Canadians keeping their Florida properties (Podcast transcript)

Posted By |
Image via Pixels/Brendon Spring

Kevin Depocas Dumas says even with current U.S.-Canada tensions he’s not seeing a lot of Canadians who want to sell their Florida properties.

In the latest episode of Two Way Traffic, he and host Darren Coleman discussed issues affecting Canadians who own property in the state. About half a million Canadians are in that boat.

Dumas is Associate Vice President of Business Development of NatBank, a wholly owned subsidiary of the National Bank of Canada that’s operated in Florida for over 30 years.

Topics he and Coleman discussed include:

  • Difficulties Canadians in the U.S. have in getting a mortgage from an American bank and what to do about it.
  • Problems Canadians in the U.S. – even wealthy ones – have in obtaining credit or getting a loan.
  • Why it’s cheaper to deal with an American financial institution than a Canadian one when in the U.S., but there could be issues you may not anticipate.

Link to podcast …

https://twowaytraffic.transistor.fm/episodes/canadians-say-they-will-stay-in-fla

Darren Coleman

Today I’m joined by Kevin Dupocas Dumas, AVP of NAT Bank in Florida. So you guys have offices in Naples. Where else?

Kevin Depocas Dumas

We have three other branches on the east coast of Florida. One in Hollywood. One in Pompano Beach. And one in Boynton Beach.

Darren Coleman

This conversation is going to be helpful for Canadians who have or want to have property in Florida. So let’s guide people through this. Who is NAT Bank?

Kevin Depocas Dumas

Kevin Depocas Dumas

NAT Bank was created 30 years ago and we are a wholly owned subsidiary of National Bank of Canada. We’ve been operating here for 30 years offering financing solutions or banking solutions primarily for Canadians. A lot of Canadians may not have access to the financing market or the banking market here. We take care of those needs for them, especially for those who spend half their year in Florida.

Darren Coleman

You and I just happened to meet each other. I was in Naples and you guys were doing a presentation in your branch for your clients. You had a cross-border attorney doing the presentation and it just happened to be my friend Shlomi Levy who’s been on this podcast. I should give full disclosure since I was a vice president at National Bank Financial for five months after they acquired HSBC. So what are some of the challenges if Canadians have property or wish to buy property in the U.S.? How easy is it to go into a U.S. bank and say I’d like a mortgage on my condo? Or a mortgage on my property? How easy is it to get a U.S.-domiciled mortgage?

Kevin Depocas Dumas

This is actually the biggest problem for Canadians coming down here. They cannot use their Canadian credit history or their Canadian assets. They’re not going to be using any documents that come from Canada. So they don’t qualify for a loan, or if they do, they have to go to the private lenders: which usually won’t do a loan at more than 50% LTV. So Canadians are not only faced with the currency exchange, but where are they going to get funds from investments they’re holding and putting it into buying the property? This is the biggest thing they’ll face here. Continue Reading…

BMO ETFs experts and finfluencers’ reveal best personal picks at DIY Investor Day

Posted By |
Courtesy BMO ETFs/TSX

On Wednesday, BMO ETFs conducted its second annual ETF Investor day. Conducted at the Toronto Stock Exchange, Do-it-yourself investors and finfluencers [Financial Influencers] were on hand for the ceremonial opening of the exchange, shown in the photo on the left (including myself).

Hard to believe, but this marks BMO’s 16th year as a Canadian ETF provider.

Before we get to the individual expert picks from BMO’s large ETF stable, the morning began with the obligatory analysis of the current Trump-inspired global trade war, and its implications for the Canadian economy and stock market.

Economic Update

In an Economic update Amber Kanwar, Host of the In the Money Podcast interviewed Bipan Rai, Head of ETF & Structured Solutions Strategy at BMO ETFs. Rai said the protectionist measures being imposed by the Trump administration have “not been seen since the Great Depression.” In the U.S. tariffs are now north of 20%, or ten times the 2% average tariffs that were previously in place.

Asked what will happen next, Rai said probably one of three things: Trump might rescind the Tariffs, or there will be a massive expansion of U.S. fiscal policy to fund its Tax Cuts, or the Federal Reserve will cut rates. But he doesn’t think a U.S. recession will show up this year, as its economy is “too dynamic.”

BMO ETFs Bipan Rai

However, Rai was less confident that Canada won’t face a Recession: “I’m very concerned about the Canadian economy in coming quarters.” The two most recent scenarios from the Bank of Canada are mixed: one is “far more benign,” the second “more malignant.” He thinks the former is more likely, with a few negative quarters of GDP growth but not likely exhibiting Stagflation risk. 70% of Canada’s GDP is generated from trade, “most of it with the U.S. As much as [Prime Minister Mark] Carney talks about diversifying away from the U.S., that’s not going to happen. The U.S. is way too big and is right next door. We may do more with the United Kingdom but it and the European Union won’t replace the U.S. Jobs may be lost, especially in the auto sector.”

Asked if he expects more rate cuts from central banks around the world, Rai said he thinks the BOC is likely closer to the end, with one or two more rate cuts, after which fiscal stimulus will kick in. England or the ECB may cut a few more times, then Japan and a few “others divorced from the rest.”

How retail investors can play Defence

Kanwar also probed the views of two experts in a session titled Playing Defense: Positioning Your Portfolio in today’s environment. Now that the U.S. market has rebounded 18% from the lows around early April’s Liberation Day, Kanwar asked how Do-it-yourself [DIY] investors can deal with volatility. Jimmy Xu, Head of Liquid Alternatives & Non-linear solutions, BMO ETFs, said it depends on investor goals. Those with a long-term 20- or 30-year time horizon before Retirement would be “best to sit tight,” Xu said, “Overtrading is the enemy of growing assets and market timing is hard.”

Freelance writer Tony Dong, founder of ETF Portfolio Blueprint, said volatility is the price of admission to create investment returns that are superior to risk-free treasury bills. Betting on certain sectors may expose DIY investors to uncompensated risk, Dong said. Even equal-weight products provide imperfect exposure to the size premium commanded by small- and mid-cap stocks. But investors can overweight less volatile stocks concentrated in structurally defensive sectors like health care, utilities and consumer staples. Jimmy Xu said sector-agnostic low-volatility strategies can help investors get around this problem. BMO’s low-volatility ETFs own low-volatility stocks that have a low beta relative to the broad market, which amounts to “a better tool than picking top sectors.” Continue Reading…